Alterity Therapeutics: Receives $640k grant from Michael J. Fox Foundation
Alterity Therapeutics (ATH) has received a US$495,000 (around A$640,428) grant from The Michael J. Fox Foundation for Parkinson's Research
The grant allows Alterity...
Alterity Therapeutics: Appoints Dr David Stamler as CEO
Alterity Therapeutics (ATH) has appointed Dr. David Stamler as CEO, effective immediately
Dr. Stamler has been with the company since June 2017, previously...

